NMS is focused on three robust “nano-medical” platforms that are distinct in application, but share a common origin of elemental silicon and nanofabrication.
The Company applies its leading-edge silicon processing and medical device expertise to the development and manufacturing of long-term drug delivery implants and peptide biomarker nanochips. Each is novel and innovative in its field.
The two nanotechnology platforms have benefited from significant academic and institutional research funding. As illustrated below, the company’s capabilities, facilities, and operations are configured to support these nano-medical platforms.